EFSA rejects Merck glucosamine-joint health claim
date:May 22, 2012
EFSAs Panel on Dietetic Products, Nutrition and Allergies (NDA) found the claim to be unsubstantiated despite Merck referencing,studies in patients with osteoarthritis, in healthy subjects, in animals and in vitro.12 of those studies were human intervention studies and there were 13 reviews.

But the Panel said the human studies which it favours did not provide a strong case that glucosamine could help joints in healthy people.

Weak

The evidence provided by consensus opinions/reports from auth
1/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/01 01:39